Advertisement
UK markets close in 7 hours 10 minutes
  • FTSE 100

    7,830.32
    -46.73 (-0.59%)
     
  • FTSE 250

    19,281.19
    -169.48 (-0.87%)
     
  • AIM

    740.57
    -4.72 (-0.63%)
     
  • GBP/EUR

    1.1676
    -0.0007 (-0.06%)
     
  • GBP/USD

    1.2438
    -0.0000 (-0.00%)
     
  • Bitcoin GBP

    52,247.57
    +3,247.90 (+6.63%)
     
  • CMC Crypto 200

    1,328.33
    +15.70 (+1.20%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CRUDE OIL

    82.99
    +0.26 (+0.31%)
     
  • GOLD FUTURES

    2,396.80
    -1.20 (-0.05%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,245.82
    -140.05 (-0.85%)
     
  • DAX

    17,680.55
    -156.85 (-0.88%)
     
  • CAC 40

    7,971.22
    -52.04 (-0.65%)
     

Merck Inc (MRK) EVP, Global Svcs & CFO Robert M Davis Sold $20.4 million of Shares

- By insider

EVP, Global Svcs & CFO of Merck Inc (30-Year Financial, Insider Trades) Robert M Davis (insider trades) sold 251,273 shares of MRK on 10/05/2020 at an average price of $81.03 a share. The total sale was $20.4 million.


Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Merck & Co Inc has a market cap of $201.4 billion; its shares were traded at around $79.63 with a P/E ratio of 19.40 and P/S ratio of 4.32. The dividend yield of Merck & Co Inc stocks is 3.06%.

ADVERTISEMENT

CFO Recent Trades:

  • EVP, Global Svcs & CFO Robert M Davis sold 251,273 shares of MRK stock on 10/05/2020 at the average price of $81.03. The price of the stock has decreased by 1.73% since.

For the complete insider trading history of MRK, click here

.This article first appeared on GuruFocus.